| Title |
Monosodium glutamate and aspartame in perceived pain in fibromyalgia
|
|---|---|
| Published in |
Rheumatology International, June 2013
|
| DOI | 10.1007/s00296-013-2801-5 |
| Pubmed ID | |
| Authors |
María Y. Vellisca, José I. Latorre |
| Abstract |
Our aim was to assess the effect of dietary elimination of monosodium glutamate (MSG) and aspartame on perceived pain in fibromyalgia. A total of 72 female patients with fibromyalgia were randomized to discontinuation of dietary MSG and aspartame (n = 36) or waiting list (n = 36). Patients were requested to rate their pain using a seven-point scale. Comparisons between both groups showed no significant differences on pain referred during the baseline or after the elimination of dietary MSG and aspartame. The discontinuation of dietary MSG and aspartame did not improve the symptoms of fibromyalgia. |
X Demographics
The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 13 | 36% |
| Czechia | 1 | 3% |
| United States | 1 | 3% |
| Congo | 1 | 3% |
| Austria | 1 | 3% |
| Unknown | 19 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 89% |
| Practitioners (doctors, other healthcare professionals) | 2 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
| Scientists | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 74 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 18 | 24% |
| Student > Master | 11 | 15% |
| Other | 7 | 9% |
| Student > Ph. D. Student | 5 | 7% |
| Student > Postgraduate | 3 | 4% |
| Other | 10 | 14% |
| Unknown | 20 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 20 | 27% |
| Medicine and Dentistry | 17 | 23% |
| Agricultural and Biological Sciences | 6 | 8% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Other | 7 | 9% |
| Unknown | 18 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2023.
All research outputs
#1,193,165
of 25,711,518 outputs
Outputs from Rheumatology International
#53
of 2,506 outputs
Outputs of similar age
#9,625
of 211,191 outputs
Outputs of similar age from Rheumatology International
#2
of 32 outputs
Altmetric has tracked 25,711,518 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,506 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,191 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.